Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3167
-0.0022 (-0.69%)
At close: Aug 25, 2025, 4:00 PM
0.3164
-0.0003 (-0.09%)
After-hours: Aug 25, 2025, 7:09 PM EDT
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $162.91K in the quarter ending June 30, 2025, a decrease of -93.87%. This brings the company's revenue in the last twelve months to $1.00M, down -89.02% year-over-year. In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%.
Revenue (ttm)
$1.00M
Revenue Growth
-89.02%
P/S Ratio
10.05
Revenue / Employee
$7,603
Employees
132
Market Cap
12.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CODX News
- 7 days ago - Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C. - PRNewsWire
- 10 days ago - Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 11 days ago - Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025 - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - GlobeNewsWire
- 3 months ago - Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire